Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 406 of 6351
-
Stool test vs. colonoscopy: new trial aims to prevent colon cancer in High-Risk patients
Prevention Recruiting nowThe ULTRA-SAFE clinical trial is a prospective, randomized study designed to address the limitations of current "one-size-fits-all" colorectal cancer surveillance guidelines. While international standards recommend a three-year follow-up colonoscopy for all high-risk patients, da…
Sponsor: National Taiwan University Hospital • Aim: Prevention
Last updated Aug 28, 2026 00:00 UTC
-
Can a gout drug and a blood thinner stop second strokes?
Disease control Not yet recruitingThe ARCHIMEDES study (Anti-inflammatory and anti-thRombotic therapy with colCHicine and low dose rIvaroxaban for Major adverse cardiovascular Events reDuction in ischEmic Stroke) will be a randomized, double-blind, 2x2 factorial clinical trial, which will include at least 3000 an…
Phase 4 • Sponsor: Brazilian Clinical Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Veterans helping veterans: One-Hour chat could save lives from firearm suicide
Prevention Not yet recruitingSuicide prevention is a top priority for the Department of Veterans Affairs (VA), with a major emphasis on developing innovative and effective ways to prevent firearm suicide. Research suggests that secure firearm storage can decrease risk for suicide and the current project aims…
Phase 1/2 • Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
New oral drug could replace steroids for severe colitis Flare-Ups
Disease control Not yet recruitingThe goal of this clinical trial is to learn if the oral medication upadacitinib can safely and effectively treat acute severe ulcerative colitis (ASUC) in adults who are hospitalized. It will also evaluate whether upadacitinib can be used without corticosteroids during initial tr…
Phase 4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New radioactive drug takes aim at Hard-to-Treat prostate cancer
Disease control Recruiting nowThis is a Phase 1b, multi-center, open-label study to evaluate the safety, tolerability, dosimetry, and pharmacokinetics (PK) of \[64Cu\]Cu-AKY-2519 and/or \[225Ac\]Ac-AKY-2519, as well as the preliminary anti-tumor activity of \[225Ac\]Ac-AKY-2519 in participants with metastatic…
Phase 1 • Sponsor: Aktis Oncology, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New hope for rare, painful skin disease: experimental drug EPN-701 enters phase 2 trial
Disease control Not yet recruitingCalciphylaxis is a rare but serious condition that leads to painful skin lesions. At present, there is no approved treatment for calciphylaxis. This research study is planned to examine the potential benefits of a new treatment (EPN-701) in patients with calciphylaxis. The presen…
Phase 2 • Sponsor: Sagar U. Nigwekar, MD, MMSc • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Hope for Huntington's: new drug aims to slow decline in major trial
Disease control Recruiting nowThe goal of this clinical trial is to learn if pridopidine can slow the clinical decline of Huntington's Disease (HD) in adult participants. It will also inform about the safety of pridopidine. The main questions the study aims to answer are: Does pridopidine slow the overall w…
Phase 3 • Sponsor: Prilenia • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug combo aims to stall bone sarcoma in phase 2 trial
Disease control Not yet recruitingThose studies demonstrate strong rationale to combine a multikinase inhibitor targeting VEGFR, PDGFR with mTOR inhibitor. Moreover, another multi-targeted TKI, lenvatinib monotherapy showed promising activity in osteosarcoma. Therefore, clinical trial with Lenvatinib in combined …
Phase 2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Nasal spray of stem cell 'Messages' could slow rare brain disease
Disease control Not yet recruitingThis study is testing a new treatment for Frontotemporal Dementia (FTD) - a progressive brain disease that affects personality, behavior, and language. Currently, there is no cure for FTD and no approved medication that can slow down or stop the disease. Existing treatments only …
Phase 1/2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a diabetes drug and immune therapy slow Alzheimer's? new trial launches
Disease control Recruiting nowAlzheimer's disease (AD) is the most common cause of dementia. Despite major research efforts, effective treatments that slow or stop disease progression remain limited. Growing evidence suggests that inflammation in the brain and the body plays a key role in the onset and progre…
Phase 1/2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Exercise program aims to boost strength in young cancer patients
Symptom relief Not yet recruitingThe BEPPO study is a Germany-wide clinical trial investigating whether a structured exercise program can improve physical and mental health in children and adolescents undergoing cancer treatment. Although exercise is known to support recovery and well-being, it is not yet a stan…
Sponsor: Universität Duisburg-Essen • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Promising drug cocktail aims to save voice boxes in throat cancer patients
Disease control Recruiting nowThis clinical trial aims to evaluate the efficacy and safety of Becotatug Vedotin (EGFR-ADC) in combination with Pucotenlimab(Anti-PD-1 Monoclonal Antibody) as neoadjuvant therapy for patients with Resectable Locally Advanced Hypopharyngeal Squamous Cell Carcinoma. The primary o…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New Once-Daily pill aims to tame ADHD symptoms in korean youth
Disease control Not yet recruitingThis is a Phase 3, randomized, double-blind, placebo-controlled, multicenter bridging clinical trial designed to evaluate the efficacy and safety of viloxazine extended-release capsules (AK-D101) compared with placebo in Korean children and adolescents aged 6 to 17 years with att…
Phase 3 • Sponsor: Alvogen Korea • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Smart breathing machines at home could cut hospital visits for COPD patients
Disease control Not yet recruitingThe purpose of this study is to evaluate the effectiveness and clinical efficiency of combining home non-invasive ventilation (NIV) with a continuous remote telemonitoring (TM) system in patients with Chronic Obstructive Pulmonary Disease (COPD) and persistent hypercapnia. In sta…
Sponsor: Air Liquide Healthcare Spain • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat cancers with specific gene deletion
Disease control Not yet recruitingThis is a Phase Ib, open-label, multicenter study of HSK41959 tablets in combination with standard therapy in patients with MTAP-deficient advanced solid tumors. The study consists of dose-escalation and dose-expansion parts and is intended to evaluate the safety, tolerability, d…
Phase 1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can eye games sharpen the mind in schizophrenia?
Disease control Not yet recruitingThe goal of this clinical trial is to determine whether a gamified eye-movement intervention can improve cognitive function in individuals across the schizophrenia spectrum, including clinical high-risk individuals, first-episode schizophrenia patients, and chronic schizophrenia …
Sponsor: Shanghai Mental Health Center • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could Pre-Surgery proton beams boost brain tumor outcomes?
Disease control Recruiting nowThe goal of this clinical trial is to learn if preopearative proton therapy (PPT) is tolerable in patients with High-grade brain gliomas. It will also learn about the influence on surgical procedure, clinical effects and safety of regular treatment. The main questions it aims to…
Phase 1 • Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can an app heal the hidden wounds of prostate cancer?
Symptom relief Recruiting nowProstate cancer (PCa) survivors frequently experience enduring psychosexual challenges following treatment, including sexual dysfunction, emotional distress, and reduced quality of life. Despite these difficulties, access to tailored support remains limited, highlighting the need…
Sponsor: Universidade do Porto • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Can a daily probiotic soothe colicky babies and calm eczema?
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate whether daily probiotic supplementation with Bifidobacterium bifidum (Bifipral® drops) can reduce crying time in formula-fed infants aged 5 months or younger diagnosed with infant colic (according to Rome IV criteria), with or withou…
Sponsor: University of Roma La Sapienza • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Zapping the brain to steady the steps of glaucoma patients?
Disease control Recruiting nowThe goal of this clinical trial is to use different tES techniques to constantly stimulate the cerebellum in older glaucoma patients. The main questions aim to answer : 1. If the different types of tES targeting the cerebellum can modulate glaucoma patients' balance function and…
Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC